Disclosure under Regulation 30 of SEBI (LODR) Regualtions, 2015

CEO resignedCFO resignedKey managerial personnel resignedManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.6%Reaction day

₹87.10

prior close

₹84.05

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.2%-5.8% vs market

Pharmaceuticals peers, median of 151sector+0.4%-5.0% vs sector

On the reaction day the stock moved 5.8 pts less than Nifty Microcap 250 and 5.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+6.9

10m

+6.8

15m

+6.8

30m

+2.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.6+1.2-5.8+0.4-5.0

Next day

-7.6+1.1-8.7+0.4-8.1

-7.5+1.4-8.9+0.5-8.0

-8.2+0.8-9.0+0.5-8.6

-7.1+0.7-7.7+0.0-7.1

-7.0-1.1-5.9-1.1-5.9

-13.6-1.9-11.7-1.9-11.7

15d

-17.9+1.6-19.5-0.1-17.8

-20.8+3.5-24.3+1.6-22.4

-27.7+0.7-28.4-2.4-25.3

-32.0+0.2-32.1-5.7-26.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Oxygenta Pharmaceutical Ltd has informed the stock exchange about two key resignations effective 18 August 2025. Mr. Vankineni Sai Sudhakar (DIN: 00733001) stepped down from his dual role as Managing Director and Chief Financial Officer, citing a change in ownership and management of the company. Separately, Mr. Sanagari Kondal Reddy (DIN: 02530466) also resigned as Independent Director for the same reason — a takeover of the company. Both resignations are voluntary and both outgoing directors confirmed there are no other material reasons for their exit. The company is a subsidiary of Virupaksha Organics Limited.

Likely market impact

The resignations of the MD, CFO, and an Independent Director — all triggered by a takeover — suggest new management is taking control. Shareholders should expect a Board reconstitution soon and watch for fresh appointments that could signal the new owner's strategic direction for the company.